Fortell venner om denne varen:
Target Validation in Drug Discovery Dillon
Har du en profil? Logg inn
Julegaver kan byttes frem til 31. januar
Få varsel om nye utgivelser fra Dillon
Legg til iMusic ønskeliste
eller
Target Validation in Drug Discovery
Dillon
Presents a comprehensive framework for approaching target validation in drug discovery. This work begins with a description of enabling technologies, including aptamers, RNA interference, and proteomics. It, then, looks at biologic drug development with discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin.
296 pages, Illustrated
| Media | Bøker Innbunden bok (Bok med hard rygg og stivt omslag) |
| Utgitt | 1. september 2006 |
| ISBN13 | 9780123693938 |
| Utgivere | Elsevier Science Publishing Co Inc |
| Antall sider | 296 |
| Mål | 184 × 260 × 24 mm · 820 g |
| Redaktør | Dillon, Susan (Senior Vice President, Discovery Research Centocor, Johnson & Johnson, Malvern, PA, U.S.A.) |
| Redaktør | Metcalf, Brian W. (Chief Drug Discovery Officer, Incyte Corporation, Moraga, CA, U.S.A.) |
